Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1998 2
2000 2
2001 2
2002 2
2003 1
2005 2
2006 5
2007 3
2008 1
2009 4
2010 3
2011 7
2012 8
2013 8
2014 18
2015 19
2016 14
2017 18
2018 10
2019 26
2020 11
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 28055295

149 results
Results by year
Filters applied: . Clear all
Page 1
IgG Fc variant cross-reactivity between human and rhesus macaque FcγRs.
Boesch AW, Miles AR, Chan YN, Osei-Owusu NY, Ackerman ME. Boesch AW, et al. MAbs. 2017 Apr;9(3):455-465. doi: 10.1080/19420862.2016.1274845. Epub 2017 Jan 5. MAbs. 2017. PMID: 28055295 Free PMC article.
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
Vafa O, Gilliland GL, Brezski RJ, Strake B, Wilkinson T, Lacy ER, Scallon B, Teplyakov A, Malia TJ, Strohl WR. Vafa O, et al. Methods. 2014 Jan 1;65(1):114-26. doi: 10.1016/j.ymeth.2013.06.035. Epub 2013 Jul 17. Methods. 2014. PMID: 23872058
Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T, Thomann M, Rueger P, Knaupp A, Buchner J, Schlothauer T. Dashivets T, et al. PLoS One. 2015 Dec 11;10(12):e0143520. doi: 10.1371/journal.pone.0143520. eCollection 2015. PLoS One. 2015. PMID: 26657484 Free PMC article.
Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.
Kolb P, Sijmons S, McArdle MR, Taher H, Womack J, Hughes C, Ventura A, Jarvis MA, Stahl-Hennig C, Hansen S, Picker LJ, Malouli D, Hengel H, Früh K. Kolb P, et al. J Virol. 2019 Feb 5;93(4):e02077-18. doi: 10.1128/JVI.02077-18. Print 2019 Feb 15. J Virol. 2019. PMID: 30487278 Free PMC article.
Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies.
Liu Z, Gunasekaran K, Wang W, Razinkov V, Sekirov L, Leng E, Sweet H, Foltz I, Howard M, Rousseau AM, Kozlosky C, Fanslow W, Yan W. Liu Z, et al. J Biol Chem. 2014 Feb 7;289(6):3571-90. doi: 10.1074/jbc.M113.513366. Epub 2013 Dec 5. J Biol Chem. 2014. PMID: 24311787 Free PMC article.
An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIaV158 Reveals That Ligation of FcγRIIIa Mediates Potent Antibody Dependent Cellular Phagocytosis With GM-CSF-Differentiated Macrophages.
Kang TH, Lee CH, Delidakis G, Jung J, Richard-Le Goff O, Lee J, Kim JE, Charab W, Bruhns P, Georgiou G. Kang TH, et al. Front Immunol. 2019 Mar 27;10:562. doi: 10.3389/fimmu.2019.00562. eCollection 2019. Front Immunol. 2019. PMID: 30984171 Free PMC article.
Cynomolgus and pigtail macaque IgG subclasses: characterization of IGHG genes and computational analysis of IgG/Fc receptor binding affinity.
Nguyen DC, Sanghvi R, Scinicariello F, Pulit-Penaloza J, Hill N, Attanasio R. Nguyen DC, et al. Immunogenetics. 2014 Jun;66(6):361-77. doi: 10.1007/s00251-014-0775-4. Epub 2014 May 9. Immunogenetics. 2014. PMID: 24811270
Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
Bruggeman CW, Dekkers G, Bentlage AEH, Treffers LW, Nagelkerke SQ, Lissenberg-Thunnissen S, Koeleman CAM, Wuhrer M, van den Berg TK, Rispens T, Vidarsson G, Kuijpers TW. Bruggeman CW, et al. J Immunol. 2017 Jul 1;199(1):204-211. doi: 10.4049/jimmunol.1700116. Epub 2017 May 31. J Immunol. 2017. PMID: 28566370 Free article.
149 results
Jump to page
Feedback